Meta-Analysis of Decision Impact and Net Decision Change in Adjuvant Chemotherapy Allocation in Early Stage Node-Negative, Estrogen Receptor-Positive Breast Cancer with a 21-Gene Assay.

Augustovski, F; Soto, N; Caporale, J; Gonzalez, L; Gibbons, L; Ciapponi, A

Augustovski, F; Soto, N; Caporale, J; Gonzalez, L; Gibbons, L; Ciapponi, A.

Afiliação

Augustovski F; Economic Evaluations & HTA Department; Institute for Clinical Effectiveness and Health Policy (IECS) and Professor of Public Health, University of Buenos Aires, Buenos Aires, Argentina.
Soto N; Institute for Clinical Effectiveness and Health Policy (IECS), Buenos Aires, Argentina.
Caporale J; Institute for Clinical Effectiveness and Health Policy (IECS), Buenos Aires, Argentina.
Gonzalez L; Institute for Clinical Effectiveness and Health Policy (IECS), Buenos Aires, Argentina.
Gibbons L; Institute for Clinical Effectiveness and Health Policy (IECS), Buenos Aires, Argentina.
Ciapponi A; Institute for Clinical Effectiveness and Health Policy (IECS), Buenos Aires, Argentina.

Value Health ; 17(7): A662, 2014 Nov.

Article em En | MEDLINE | ID: mdl-27202411

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2014 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2014 Tipo de documento: Article